Erik Spaepen

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005

Lieven Annemans, Erik Spaepen, M. Gaskin et al. · Annals of the Rheumatic Diseases · 2007 · 496 citations · Full text

Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia

Gregor Theilmeier, Carine Michiels, Erik Spaepen et al. · Blood · 2002 · 183 citations · Full text

Health economic consequences related to the diagnosis of fibromyalgia syndrome

Lieven Annemans, Simon Wessely, Erik Spaepen et al. · Arthritis & Rheumatism · 2008 · 145 citations

Long-Term Outcome of Prostatic Artery Embolization for Patients with Benign Prostatic Hyperplasia: Single-Centre Retrospective Study in 1072 Patients Over a 10-Year Period

Tiago Bilhim, Nuno Vasco Costa, Daniel Torres et al. · CardioVascular and Interventional Radiology · 2022 · 76 citations

Urology, Long-term Outcome, Benign Prostatic Hyperplasia +2

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study)

Mamas A. Mamas, Farzin Fath‐Ordoubadi, Gian Battista Danzi et al. · The American Journal of Cardiology · 2015 · 62 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Health Policy +11